Review
doi: 10.1038/nrc1650.
Repopulation of cancer cells during therapy: an important cause of treatment failure
Affiliations
- PMID: 15965493
- DOI: 10.1038/nrc1650
Item in Clipboard
Review
Repopulation of cancer cells during therapy: an important cause of treatment failure
Nat Rev Cancer.
2005 Jul.
Abstract
Radiotherapy and chemotherapy are given in multiple doses, which are spaced out to allow the recovery of normal tissues between treatments. However, surviving cancer cells also proliferate during the intervals between treatments and this process of repopulation is an important cause of treatment failure. Strategies developed to overcome repopulation have improved clinical outcomes, and now new strategies to inhibit repopulation are emerging in parallel with advances in the understanding of underlying biological mechanisms.
Similar articles
-
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16414206 Clinical Trial.
-
Consequences of mucositis-induced treatment breaks and dose reductions on head and neck cancer treatment outcomes.J Support Oncol. 2007 Oct;5(9 Suppl 4):23-31. J Support Oncol. 2007. PMID: 18046995 Review.
-
Radiation therapy toxicity to the skin.Dermatol Clin. 2008 Jan;26(1):161-72, ix. doi: 10.1016/j.det.2007.08.005. Dermatol Clin. 2008. PMID: 18023776 Review.
-
EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.Radiother Oncol. 2007 Jun;83(3):238-48. doi: 10.1016/j.radonc.2007.04.006. Epub 2007 May 14. Radiother Oncol. 2007. PMID: 17502118 Review.
-
Alternation of chemotherapy and radiotherapy in cancer management. I. Summary of the Division of Cancer Treatment Workshop.Cancer Treat Rep. 1985 Jul-Aug;69(7-8):769-75. Cancer Treat Rep. 1985. PMID: 4016787 No abstract available.
Cited by
-
Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval.J Contemp Brachytherapy. 2020 Jun;12(3):216-224. doi: 10.5114/jcb.2020.96861. Epub 2020 Jun 30. J Contemp Brachytherapy. 2020. PMID: 32695192 Free PMC article.
-
Mechanism-based screen establishes signalling framework for DNA damage-associated G1 checkpoint response.PLoS One. 2012;7(2):e31627. doi: 10.1371/journal.pone.0031627. Epub 2012 Feb 27. PLoS One. 2012. PMID: 22384045 Free PMC article.
-
Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis.Oncotarget. 2016 Nov 8;7(45):73032-73044. doi: 10.18632/oncotarget.12195. Oncotarget. 2016. PMID: 27682876 Free PMC article.
-
Multispecies model of cell lineages and feedback control in solid tumors.J Theor Biol. 2012 Jul 7;304:39-59. doi: 10.1016/j.jtbi.2012.02.030. Epub 2012 Mar 31. J Theor Biol. 2012. PMID: 22554945 Free PMC article.
-
Dual-targeting nanomicelles with CD133 and CD44 aptamers for enhanced delivery of gefitinib to two populations of lung cancer-initiating cells.Exp Ther Med. 2020 Jan;19(1):192-204. doi: 10.3892/etm.2019.8220. Epub 2019 Nov 19. Exp Ther Med. 2020. PMID: 31853290 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
